BRAIN on growth track in the first half-year 2016/17
B.R.A.I.N. Biotechnology Research and Information Network AG published its financial results for the first half of fiscal year 2016/17.
Accordingly, during the reporting period from October 1, 2016, to March 31, 2017, the BRAIN Group grew its total operating performance by 3 percent from € 13.0 million to € 13.3 million. This development was driven mainly by the strong growth of the BioScience segment in the second quarter.
At the same time, revenues of BRAIN Group increased by 9 percent from € 11.2 million to € 12.1 million. The half-year EBIT was down from € -5.3 million to € -5.6 million mostly due to first quarter special items with no impact on liquidity. The BioIndustrial segment generated a positive EBIT contribution of € 0.2 million.
The operating cash flow developed positively, amounting to € -2.3 million compared to € -4.6 million in the previous year period.
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.